These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19023227)

  • 21. Detection of hepatitis B surface antigen in aqueous humor.
    Temel A; Seber E; Gunay M
    Acta Ophthalmol (Copenh); 1990 Apr; 68(2):205-8. PubMed ID: 2356709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China.
    Fang Y; Shang QL; Liu JY; Li D; Xu WZ; Teng X; Zhao HW; Fu LJ; Zhang FM; Gu HX
    J Infect; 2009 May; 58(5):383-8. PubMed ID: 19329189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
    Said ZN; El-Sayed MH; El-Bishbishi IA; El-Fouhil DF; Abdel-Rheem SE; El-Abedin MZ; Salama II
    Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: differential pattern of mutations, liver injury and occult HBV infection.
    Chandra PK; Biswas A; Datta S; Banerjee A; Panigrahi R; Chakrabarti S; De BK; Chakravarty R
    J Viral Hepat; 2009 Oct; 16(10):749-56. PubMed ID: 19457142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The changing epidemiology of viral hepatitis B in Iran.
    Alavian SM; Fallahian F; Lankarani KB
    J Gastrointestin Liver Dis; 2007 Dec; 16(4):403-6. PubMed ID: 18193122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia.
    Panessa C; Hill WD; Giles E; Yu A; Harvard S; Butt G; Andonov A; Krajden M; Osiowy C
    J Viral Hepat; 2009 Jan; 16(1):64-73. PubMed ID: 19192159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiological study of genotypes of hepatitis B virus in northern Portugal.
    Mota A; Guedes F; Areias J; Pinho L; Cardoso MF
    J Med Virol; 2009 Jul; 81(7):1170-6. PubMed ID: 19475628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotyping of acute HBV isolates from England, 1997-2001.
    Sloan RD; Strang AL; Ramsay ME; Teo CG
    J Clin Virol; 2009 Feb; 44(2):157-60. PubMed ID: 19131271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus.
    Chu CM; Liaw YF
    Am J Gastroenterol; 2009 Jul; 104(7):1693-9. PubMed ID: 19455130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The reality of risk and the recent evolution of infection control.
    Molinari JA
    Compendium; 1994 Feb; 15(2):148, 150-1. PubMed ID: 8055502
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevalence of hepatitis B and C: a Jinnah Postgraduate Medical Centre experience.
    Sami S; Korejo R; Bhutta SZ
    J Obstet Gynaecol Res; 2009 Jun; 35(3):533-8. PubMed ID: 19527395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transmission of hepatitis B virus in correctional facilities--Georgia, January 1999-June 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Aug; 53(30):678-81. PubMed ID: 15295311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and virological survey of patients with hepatitis B surface antigen in an Italian region: clinical considerations and disease burden.
    Torre F; Basso M; Giannini EG; Feasi M; Boni S; Grasso A; De Leo P; Dodi F; Marazzi MG; Azzola E; Bartolacci V; Percario G; Beltrame A; Borro P; Picciotto A;
    J Med Virol; 2009 Nov; 81(11):1882-6. PubMed ID: 19774694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High risk of hepatitis B-virus reactivation after hematopoietic cell transplantation in hepatitis B core antibody-positive patients.
    Matsue K; Aoki T; Odawara J; Fujiwara H; Iwama K; Kimura S; Yamakura M; Takeuch M
    Eur J Haematol; 2009 Oct; 83(4):357-64. PubMed ID: 19508685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recommendations for the management of HBV-infected health care providers.
    Michigan Department of Community Health
    Mich Med; 2012; 111(5):20-1. PubMed ID: 23167043
    [No Abstract]   [Full Text] [Related]  

  • 37. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus and hepatitis C virus in medical waste handlers in Tripoli, Libya.
    Franka E; El-Zoka AH; Hussein AH; Elbakosh MM; Arafa AK; Ghenghesh KS
    J Hosp Infect; 2009 Jul; 72(3):258-61. PubMed ID: 19443080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the risk of hepatitis B reactivation in patients with haematological malignancies: is the serum hepatitis B virus profile reliable?
    Ferraro D; Pizzillo P; Di Marco V; Vultaggio A; Iannitto E; Venezia G; Craxì A; Di Stefano R
    Liver Int; 2009 Sep; 29(8):1171-7. PubMed ID: 19602139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of hepatitis B virus infection in the Middle East.
    Qirbi N; Hall AJ
    East Mediterr Health J; 2001 Nov; 7(6):1034-45. PubMed ID: 15332746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.